Skip to main content
. 2024 Feb 16;13(3):193–203. doi: 10.1093/stcltm/szad088

Table 2.

Safety data at 6 months of follow-up.

LD group
n = 16
MD group
n = 16
HD group
n = 8
Injection-related AE
Synovitis, n (%) 0 1 (6,2) 3 (37.5)
Clinically significant pain*, n (%) 6 (37,5) 11 (68,7) 8 (100)
Infection, n (%) 0 0 0
Fever, n (%) 1 (6,2) 0 0

Data are presented as n.

Abbreviation: AE, adverse events.